Z
Zhongke Guosheng Technology
A bio-based materials R&D firm that designs and develops furan-based bio-based materials
About Zhongke Guosheng Technology
Zhongke Guosheng Technology (Hangzhou) Co., Ltd. is a high-tech enterprise focused on the research, development, and industrialization of furan-based biomaterials. Founded in July 2021, the company is strategically positioned to capitalize on the growing demand for sustainable alternatives to petrochemicals, driven by global carbon neutrality goals.
The company was established by Dr. Wang Lei, who holds a Ph.D. from the Dalian Institute of Chemical Physics, Chinese Academy of Sciences. Dr. Wang and the core founding team bring nearly two decades of research and industrialization experience in biomass catalytic conversion, having graduated from prominent institutions like the Dalian Institute of Chemical Physics and Tsinghua University. This deep technical background is a cornerstone of the company's strategy, enabling the development of proprietary processes for producing key platform compounds.
Zhongke Guosheng's core business revolves around the production and sale of 5-hydroxymethylfurfural (HMF) and its derivatives. HMF is a crucial bio-based platform chemical that can be converted into a wide array of high-value products, including polymers, resins, and fine chemicals, serving industries from packaging to pharmaceuticals. The company has developed a continuous fixed-bed production process for HMF, a significant advancement over traditional batch kettle methods, which results in higher efficiency, lower production costs, and more consistent product quality. This process has been a key factor in reducing HMF's cost, making its large-scale application economically viable.
The company's product portfolio includes HMF and downstream derivatives like 2,5-furandicarboxylic acid (FDCA), 2,5-tetrahydrofuran dimethanol (THFDM), and polyethylene furanoate (PEF). FDCA, in particular, is a critical monomer for producing PEF, a bio-based polymer with superior gas barrier properties compared to traditional PET, making it ideal for food, beverage, and medical packaging. Zhongke Guosheng has successfully scaled production, delivering ton-level orders of high-purity FDCA to major overseas polyester enterprises.
The company operates on a B2B model, supplying these bio-based materials to manufacturers in sectors such as high-performance polyesters, surfactants, and specialty chemicals. Zhongke Guosheng has secured significant funding to support its growth, including a Series A+ round of 200 million Yuan in March 2025 and a Pre-A round of nearly 100 million Yuan in December 2022. These funds are allocated towards expanding production capacity, with plans for a 10,000-ton facility in Taixing, Jiangsu, and furthering research and development.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2025 | — | — | Hangzhou Capital · Shanghai Yunhui Equity Investment Management · Puhua Capital · CITIC Gold Stone Investment | ↗ |
| EARLY VC✓Equity / VC | Mar 2024 | $14M | $55M | Legend Capital · Meridian Capital Asia · Junsheng Investment | ↗ |
Growth signals
Latest recorded traffic for Zhongke Guosheng Technology is 450 monthly website visits, up 200% over the last three months. Zhongke Guosheng Technology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Zhongke Guosheng Technology in the Hangzhou ecosystem
The Zhongke Guosheng Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- JCJunsan Capital
Legend Capital- CCCountry Garden Venture Capital
Series A8 investors entered at this stage
- JIJunsheng Investment
- ZCZhongding Capital
- HVHuaying VC
Meridian Capital Asia
Hangzhou Capital- SMShanghai Yunhui Equity Investment Management
- PCPuhua Capital
CITIC Gold Stone Investment
Other known investors1 additional known investor
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Zhongke Guosheng Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Zhongke Guosheng Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





